Advertisement
Screener

NephroGenex, Inc. Net Cash Provided by (Used in) Continuing Operations

NephroGenex, Inc. Net Cash Provided by (Used in) Continuing Operations

NephroGenex, Inc. reported Net Cash Provided by (Used in) Continuing Operations of $4.85 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2016-03-29

  • NephroGenex, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-12-31 was -$420.00K, a 107.04% decline year-over-year.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-09-30 was $9.05M.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-06-30 was -$6.17M.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was $2.38M, a 92.40% decline year-over-year.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for fiscal 2015 was $4.85M, a 59.04% decline from fiscal 2014.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was $11.85M, a 555.20% increase from fiscal 2013.
  • NephroGenex, Inc. net cash provided by (used in) continuing operations for fiscal 2013 was $1.81M.
Period endNet Cash Provided by (Used in) Continuing Operations 3 monthNet Cash Provided by (Used in) Continuing Operations 3 month as first filedNet Cash Provided by (Used in) Continuing Operations 6 monthNet Cash Provided by (Used in) Continuing Operations 9 monthNet Cash Provided by (Used in) Continuing Operations 12 monthNet Cash Provided by (Used in) Continuing Operations 118 month
2015-12-31-$420.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$8.63M
derived: sum of 2 quarters · filed 2016-03-29
$2.47M
derived: sum of 3 quarters · filed 2016-03-29
$4.85M
10-K · filed 2016-03-29
2015-09-30$9.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$2.89M
derived: sum of 2 quarters · filed 2015-11-12
$5.27M
10-Q · filed 2015-11-12
$11.23M
derived: sum of 4 quarters · filed 2016-03-29
2015-06-30-$6.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
-$3.78M
10-Q · filed 2015-08-12
$2.18M
derived: sum of 3 quarters · filed 2016-03-29
-$1.42M
derived: sum of 4 quarters · filed 2016-03-29
2015-03-31$2.38M
10-Q · filed 2015-05-13
$8.35M
derived: sum of 2 quarters · filed 2016-03-29
$4.74M
derived: sum of 3 quarters · filed 2016-03-29
-$17.15M
derived: sum of 4 quarters · filed 2016-03-29
2014-12-31$5.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$2.36M
derived: sum of 2 quarters · filed 2016-03-29
-$19.54M
derived: sum of 3 quarters · filed 2016-03-29
$11.85M
10-K · filed 2016-03-29
2014-09-30-$3.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$25.50M
derived: sum of 2 quarters · filed 2015-11-12
$5.88M
10-Q · filed 2015-11-12
$7.81M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30-$21.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$9.49M
10-Q · filed 2015-08-12
$11.42M
derived: sum of 3 quarters · filed 2015-08-12
$11.41M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$31.38M
10-Q · filed 2015-05-13
$31.38M
10-Q · filed 2014-05-14
$33.31M
derived: sum of 2 quarters · filed 2015-05-13
$33.30M
derived: sum of 3 quarters · filed 2015-05-13
$33.17M
derived: sum of 4 quarters · filed 2015-05-13
$33.51M
10-Q · filed 2014-05-14
2013-12-31$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24
$1.92M
derived: sum of 2 quarters · filed 2015-03-24
$1.79M
derived: sum of 3 quarters · filed 2015-03-24
$1.81M
10-K · filed 2015-03-24
2013-09-30-$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
-$143.25K
derived: sum of 2 quarters · filed 2014-11-12
-$122.00K
10-Q · filed 2014-11-12
2013-06-30-$135.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
-$114.00K
10-Q · filed 2014-08-12
2013-03-31$21.25K
10-Q · filed 2014-05-14